You are here PRODUCTS >> CELL LINES >> iPSc & iPSc DERIVATIVES >> iPS cells
PRODUCTS
Human iPS CELLS
Celther Polska offers human induced pluripotent stem cells (human iPSc), which can be easily differentiated to iNS cells, induced cardiomyocytes or hepatocytes as well as other specialised cell lines.
Description
Celther Cat. No.:
CLTH/iPS cells
CL 05001-CLTH
APPLICATIONS
Drug discovery - Toxicity screening - Differentiation and fate choice - Tissue and organ development - Epigenetic profiling - Disease modelling
APPLICATION hiPS cells in the Drug Discovery proces
- Understand underlying mechanisms of disease in human cells
- Indentify drug targets, diagnostics, prognostics
- Screen for and test drugs or leads-to-drugs
- Provide better predictive models of drug efficacy and toxicity
GENERAL INFORMATION
Immunofluorescent studies indicate expression of transcription factors (Sox2, Oct4, Nanog) as well as surface proteins (Tra1-81 and Tra1-60) characteristic for iPS cells. Furthermore, Celther iPS cells retain the ability to differentiate to cells originating from all three germ layers. Induced pluripotent stem cells have been derived from human dermal fibroblast.
Please look at more information - CELTHER hIPSc BROCHURE
SPECIFICATIONS
General Specifications
Form:
Cryopreserved
Format:
Vial(s)
Species:
Human
Quantity:
1 vial
Cell Type:
Human Induced pluripotent stem cells
Culture Type:
Adherent Cell Culture
Donor Source:
Single Donor
Product Size:
1 mL
Number of Cells:
1x106
Tests Performed:
Sterility Testing (Bacteria & Fungi)
Donor Attributes:
Normal
Regulatory Statement:
For Research Use Only. Not for use in diagnostic procedures.
iPS cells are tested and free of microbial contamination.
iPS cells are shipped with dry ice and provided to customers in cryovials containing at least 1 x 10 6 cells/mL.
For iPS cells Celther Polska recommends optimal growth medium (MED 02006-CLTH), which maintains them in the undifferentiated state and provides conditions for infinite number of divisions.
iPS cells are shipped with dry ice and provided to customers in cryovials containing at least 1 x 10 6 cells/mL.
For iPS cells Celther Polska recommends optimal growth medium (MED 02006-CLTH), which maintains them in the undifferentiated state and provides conditions for infinite number of divisions.